Evidence map›Paper›PMID 38523640›Full record

ArticleFrontiers in pharmacology2024

Anti-diabetic and anti-inflammatory bioactive hits from

Mavis Colleen Porciuncula Fabian, Rezzaira Marie Neduelan Astorga, Arnelson Arwin Gray Atis, Luis Agustin Elido Pilapil, Christine Chichioco Hernandez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mavis Colleen Porciuncula Fabian *Bioorganic and Natural Products Laboratory, Institute of Chemistry, University of the Philippines Diliman, Quezon City, Philippines.
Rezzaira Marie Neduelan Astorga *Bioorganic and Natural Products Laboratory, Institute of Chemistry, University of the Philippines Diliman, Quezon City, Philippines.
Arnelson Arwin Gray Atis *Bioorganic and Natural Products Laboratory, Institute of Chemistry, University of the Philippines Diliman, Quezon City, Philippines.
Luis Agustin Elido Pilapil *Bioorganic and Natural Products Laboratory, Institute of Chemistry, University of the Philippines Diliman, Quezon City, Philippines.
Christine Chichioco HernandezBioorganic and Natural Products Laboratory, Institute of Chemistry, University of the Philippines Diliman, Quezon City, Philippines.
University of the Philippines Diliman · PH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Women have been found to be at a higher risk of morbidity and mortality from type 2 diabetes mellitus (T2DM) and asthma. α-Glucosidase inhibitors have been used to treat T2DM, and arachidonic acid 15-lipoxygenase (ALOX15) inhibitors have been suggested to be used as treatments for asthma and T2DM. Compounds that inhibit both enzymes may be studied as potential treatments for people with both T2DM and asthma. This study aimed to determine potential anti-diabetic and anti-inflammatory bioactive hits from

Indexed as

15-lipoxygenase-1anti-diabeticanti-inflammationdereplicationenzyme inhibitionLC-MS/MSterrestrial plantsα-glucosidase

Identifiers

PMID38523640
PMCPMC10957545
OpenAlexW4392593366

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.